Type 2 diabetes models

Dorte Xenia Gram

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskningpeer review

    Resumé

    This chapter deals with type 2 diabetes in vivo models and techniques suitable for testing new anti-diabetic compounds. In particular, the testing of TRP antagonist for beneficial effects against type 2 diabetes is considered. There are many choices of both in vitro techniques and in vivo models and in principle they can be combined in various ways. The comprehensive listing of all relevant tests and models is too long to be discussed and described in detail here. Therefore, a few selected in vivo experiments (author's models of choice) are described. These are acute experiments after single dose of the TRP antagonist in rodents and could/should be repeated after chronic dosing. Non-rodent models are briefly discussed, and a single model and test are suggested but not described in detail. The experiments are aiming at demonstrating that the TRP antagonists are effective in treating hyperglycemia, impaired glucose tolerance, impaired insulin secretion, and insulin resistance in vivo and should, thus, be sufficient to demonstrate preclinical proof of concept of a TRP antagonist in type 2 diabetes in rodents. The experiments are suggestions and could be replaced or supplemented by others.
    OriginalsprogEngelsk
    TitelMethods in Pharmacology and Toxicology
    RedaktørerA. Szallasi, T. Biro
    Vol/bind2012
    Udgivelses stedNew York
    ForlagSpringer
    Publikationsdato2012
    Sider319-332
    ISBN (Trykt)978-162703094-6
    DOI
    StatusUdgivet - 2012
    NavnMethods in Pharmacology and Toxicology
    ISSN1557-2153

    Citer dette

    Gram, D. X. (2012). Type 2 diabetes models. I A. Szallasi, & T. Biro (red.), Methods in Pharmacology and Toxicology (Bind 2012, s. 319-332). New York: Springer. Methods in Pharmacology and Toxicology https://doi.org/10.1007/978-1-62703-095-3_20
    Gram, Dorte Xenia. / Type 2 diabetes models. Methods in Pharmacology and Toxicology . red. / A. Szallasi ; T. Biro. Bind 2012 New York : Springer, 2012. s. 319-332 (Methods in Pharmacology and Toxicology).
    @inbook{4136aaa614554efc880a0b6ff7fc2b74,
    title = "Type 2 diabetes models",
    abstract = "This chapter deals with type 2 diabetes in vivo models and techniques suitable for testing new anti-diabetic compounds. In particular, the testing of TRP antagonist for beneficial effects against type 2 diabetes is considered. There are many choices of both in vitro techniques and in vivo models and in principle they can be combined in various ways. The comprehensive listing of all relevant tests and models is too long to be discussed and described in detail here. Therefore, a few selected in vivo experiments (author's models of choice) are described. These are acute experiments after single dose of the TRP antagonist in rodents and could/should be repeated after chronic dosing. Non-rodent models are briefly discussed, and a single model and test are suggested but not described in detail. The experiments are aiming at demonstrating that the TRP antagonists are effective in treating hyperglycemia, impaired glucose tolerance, impaired insulin secretion, and insulin resistance in vivo and should, thus, be sufficient to demonstrate preclinical proof of concept of a TRP antagonist in type 2 diabetes in rodents. The experiments are suggestions and could be replaced or supplemented by others.",
    author = "Gram, {Dorte Xenia}",
    year = "2012",
    doi = "10.1007/978-1-62703-095-3_20",
    language = "English",
    isbn = "978-162703094-6",
    volume = "2012",
    pages = "319--332",
    editor = "A. Szallasi and T. Biro",
    booktitle = "Methods in Pharmacology and Toxicology",
    publisher = "Springer",

    }

    Gram, DX 2012, Type 2 diabetes models. i A Szallasi & T Biro (red), Methods in Pharmacology and Toxicology . bind 2012, Springer, New York, Methods in Pharmacology and Toxicology, s. 319-332. https://doi.org/10.1007/978-1-62703-095-3_20

    Type 2 diabetes models. / Gram, Dorte Xenia.

    Methods in Pharmacology and Toxicology . red. / A. Szallasi; T. Biro. Bind 2012 New York : Springer, 2012. s. 319-332 (Methods in Pharmacology and Toxicology).

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskningpeer review

    TY - CHAP

    T1 - Type 2 diabetes models

    AU - Gram, Dorte Xenia

    PY - 2012

    Y1 - 2012

    N2 - This chapter deals with type 2 diabetes in vivo models and techniques suitable for testing new anti-diabetic compounds. In particular, the testing of TRP antagonist for beneficial effects against type 2 diabetes is considered. There are many choices of both in vitro techniques and in vivo models and in principle they can be combined in various ways. The comprehensive listing of all relevant tests and models is too long to be discussed and described in detail here. Therefore, a few selected in vivo experiments (author's models of choice) are described. These are acute experiments after single dose of the TRP antagonist in rodents and could/should be repeated after chronic dosing. Non-rodent models are briefly discussed, and a single model and test are suggested but not described in detail. The experiments are aiming at demonstrating that the TRP antagonists are effective in treating hyperglycemia, impaired glucose tolerance, impaired insulin secretion, and insulin resistance in vivo and should, thus, be sufficient to demonstrate preclinical proof of concept of a TRP antagonist in type 2 diabetes in rodents. The experiments are suggestions and could be replaced or supplemented by others.

    AB - This chapter deals with type 2 diabetes in vivo models and techniques suitable for testing new anti-diabetic compounds. In particular, the testing of TRP antagonist for beneficial effects against type 2 diabetes is considered. There are many choices of both in vitro techniques and in vivo models and in principle they can be combined in various ways. The comprehensive listing of all relevant tests and models is too long to be discussed and described in detail here. Therefore, a few selected in vivo experiments (author's models of choice) are described. These are acute experiments after single dose of the TRP antagonist in rodents and could/should be repeated after chronic dosing. Non-rodent models are briefly discussed, and a single model and test are suggested but not described in detail. The experiments are aiming at demonstrating that the TRP antagonists are effective in treating hyperglycemia, impaired glucose tolerance, impaired insulin secretion, and insulin resistance in vivo and should, thus, be sufficient to demonstrate preclinical proof of concept of a TRP antagonist in type 2 diabetes in rodents. The experiments are suggestions and could be replaced or supplemented by others.

    U2 - 10.1007/978-1-62703-095-3_20

    DO - 10.1007/978-1-62703-095-3_20

    M3 - Book chapter

    SN - 978-162703094-6

    VL - 2012

    SP - 319

    EP - 332

    BT - Methods in Pharmacology and Toxicology

    A2 - Szallasi, A.

    A2 - Biro, T.

    PB - Springer

    CY - New York

    ER -

    Gram DX. Type 2 diabetes models. I Szallasi A, Biro T, red., Methods in Pharmacology and Toxicology . Bind 2012. New York: Springer. 2012. s. 319-332. (Methods in Pharmacology and Toxicology). https://doi.org/10.1007/978-1-62703-095-3_20